Position in EVGN
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$4,071
-$3,310 QoQ
Shares Held
9,253
-3.5% QoQ
Ownership
0.059%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#6
of 13 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EVGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Daytona Street Capital LLC holds $2,589,685 across 6 Biotechnology names. EVGN ranks #5 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DRTS |
Alpha Tau Medical Ltd.
|
146,106 | $1,838,013 | |
| 2 | OBIO |
Orchestra BioMed Holdings, Inc.
|
96,398 | $415,957 | |
| 3 | ELDN |
Eledon Pharmaceuticals, Inc.
|
81,166 | $319,794 | |
| 4 | MAIA |
MAIA Biotechnology, Inc.
|
7,500 | $10,800 | |
| 5 | EVGN |
Evogene Ltd.
This page
|
9,253 | $4,071 | |
| 6 | MRNA |
Moderna, Inc.
|
15 | $1,050 |
All Filings in EVGN
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,071 | 9,253 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $7,381 | 9,586 | Shares | Sole | 2026-04-10 | |
| 2025-12-31 | $10,544 | 9,586 | Shares | Sole | 2026-01-21 | |
| No filing history on record for this holder in this stock. | ||||||